Clinical trials: Hereditary Spherocytosis
Hereditary, Hemolysis
Hemolysis in Patients With Hereditary Spherocytosis (HS)
In the present study the investigators are going to explore the oxidative status of HS-RBC and its contribution to hemolysis
- Trial name
- NCT01201174
- Testing
- fermented papaya preparation (FPP)
- Where
- Israel
- Volunteers
- 15 people, healthy volunteers welcome
- Sponsor
- Wolfson Medical Center
Hereditary Spherocytosis, Hemolytic Anemia
New CBC Parameters in Diagnosis of Hereditary Spherocytosis
This cross-sectional study aims to evaluate the diagnostic performance of selected automated complete blood count-derived erythrocytic and reticulocytic parameters in children with hereditary spherocytosis.
- Trial name
- NCT07842718
- Volunteers
- 41 people, healthy volunteers welcome
- Sponsor
- Assiut University
Hereditary Spherocytosis
Hereditary Spherocytosis and Vascular Function
Background : Patients with hereditary spherocytosis (HS) are characterized by increased red blood cell (RBC) fragility and a loss of RBC deformability.
- Trial name
- VASCUSPHERO (NCT04451785)
- Testing
- blood sample, Pulse wave velocity
- Where
- 2 sites in France
- Volunteers
- 72 people, healthy volunteers welcome
- Sponsor
- Hospices Civils de Lyon